Sumitomo Mitsui Trust Group, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for Arcturus Therapeutics Holdings Inc. Common stock, par value $0.001 per share (ARCT)

Filing Manager
Sumitomo Mitsui Trust Group, Inc.
Reporting Manager
Sumitomo Mitsui Trust Group, Inc.
Security
Arcturus Therapeutics Holdings Inc. Common stock, par value $0.001 per share
Symbol
ARCT
Shares outstanding
27,127,944 shares
Disclosed Ownership
1,926,084 shares
Ownership
7.1%
Form type
SCHEDULE 13G/A
Filing time
25 Apr 2025, 06:18:10 UTC
Date of event
31 Mar 2025
Next filing
27 Oct 2025
SEC
View on sec.gov

Quoteable Key Fact

"Sumitomo Mitsui Trust Group, Inc. disclosed 7.1% ownership in Arcturus Therapeutics Holdings Inc. Common stock, par value $0.001 per share (ARCT) on 31 Mar 2025."

Quick Takeaways

  • Sumitomo Mitsui Trust Group, Inc. filed SCHEDULE 13G/A for Arcturus Therapeutics Holdings Inc. Common stock, par value $0.001 per share (ARCT).
  • Disclosed ownership: 7.1%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 25 Apr 2025, 06:18.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sumitomo Mitsui Trust Group, Inc. 7.1% 1,926,084 0 1,926,084 Hideaki Takamiya Head of Business Regulatory Compliance
Nikko Asset Management Co., Ltd. 7.1% 1,926,084 0 1,926,084 Atsushi Ohya Head of Business Regulatory Compliance